Expression of adhesion molecule CD44 in metastatic brain tumors

Folia Neuropathologica

Volumn 36, Issue 3, 1998, Pages 178-184

  Harabin Słowińska, Marzena ^a,b   Słowiński, Jerzy ^a   Konecki, Janusz ^a   Mrówka, Ryszard ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Dept Neurosurg Neurotraumatology Silesian School of Medicine ^*  (Poland)

Author keywords

CD44 glycoprotein; Cell adhesion; Metastatic brain tumors

Indexed keywords

EID: 84901326124     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aho R, Kalimo H, Salmi M, Smith D, Jalkanen S: Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol, 1997, 56, 557-568.
2. Albelda SM: Role of integrins and other cells adhesion molecules in tumor progression and metastasis. Lab Invest, 1993, 68, 4-17.
3. Bartalozzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in regulation of tumor development. J Exp Med, 1994, 180, 53-66.
4. Bindai RK, Sawaya R, Leavens ME, Lee J: Surgical treatment of multiple brain metastases. J Neurosurg, 1993, 79, 210-216.
5. Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P: Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumor stroma. Eur J Cancer, 1993, 29A, 1012-1017.
6. East JA, Hart IR: CD44 and its role in tumour progression and metastasis. Eur J Cancer, 1993, 29A, 1921-1922.
7. Eibl RH, Pietsch T, Moll J, Skroch-Angel P, Heider KH, von Ammon K, Wiestler OD, Ponta H, Kleihues P, Herrlich P: Expression of variant CD44 epitopes in human astrocytic brain tumors. J Neurooncol, 1995, 26, 165-170.
8. Gingras MC, Roussel E, Bruner JM, Branch CD, Moser RP: Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol, 1995, 57, 143-153.
9. Girgrach N, Letarte M, Becker LE, Cruz TF, Theriault, Moscarello MA: Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol, 1991, 50, 779-792.
10. Górski A: The role of adhesion molecules in immunopathology. Immunol Today, 1994, 15, 251-255.
11. Gunthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumour progression? Cancer Surv, 1995, 24, 19-42.
12. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy M-S: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res, 1994, 54, 1561-1565.
13. Hart IR, Saini A: Biology of tumor metastasis. Lancet, 1992, 339, 1453-1457.
14. Herrlich P, Zoller M, Pals ST, Ponta H: CD44 splice variants: metastases meet lymphocytes. Immunol Today, 1993, 14, 395-399.
15. Honn KV, Tang DG: Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev, 1992, 11, 353-375.
16. Jalkanen S, Joensuu H, Soderstrom KO, Klemi PJ: Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invets, 1991, 87, 1835-1840.
17. Joensuu H, Klemi PJ, Toikannen S, Jalkanen S: Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol, 1993, 143, 867-874.
18. Koochekpour S, Pilkington GJ, Merzak A: Hyaluric acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer, 1995, 63, 450-454.
19. Kuppner MC, Van Meir E, Gauthier T, Hamou MF, De Tribolet N: Differential expression of the CD44 molecule in human brain tumours. Int J Cancer, 1992, 50, 572-577.
20. Li H, Liu J, Hofmann M, Hamou MF, de Tribolet N: Differential CD44 expression patterns in primary brain tumours and brain metastases. Br J Cancer, 1995, 72, 160-163.
21. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res, 1994, 54, 3988-3992.
22. Nagasaka S, Tanabe KT, Bruner JM, Saya H, Sawaya RE, Morrison RS: Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg, 1995, 82, 858-863.
23. Penno MB, August JT, Baylin SB: Expression of CD44 in human lung tumors. Cancer Res, 54, 1381-1387.
24. Pilkington GJ: Tumour cell migration in the central nervous system. Brain Pathol, 1994, 4, 157-166.
25. Rossler K, Neuchrist C, Kitz K, Scheiner O, Kraft D, Lassman H: Expression of leukocyte adhesion molecules at the human blood-brain barrier (BBB). J. Neurosci Res, 1992, 31, 365-374.
26. Radotra B, McCormick D: Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J Pathol, 1997, 181, 434-438.
27. Roos E: Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev, 1991, 10, 33-48.
28. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M: Prevention of tumor metastasis formation by anti-variant of CD44 (CD44v). J Exp Med, 1993, 177, 443-455.
29. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA: Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 1996, 122, 627-632.
30. Wroński M: Statistics of brain metastases (in Polish). Neurol Neurochir Pol, 1995, 29, 961-968.
31. Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J, Hyman R, Hamik A, Parkhouse RME, Farr AG, Kincade PW: Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol, 1995, 130, 485-495.